The Impact of Reimbursement Policies and Practices on Healthcare Technology Innovation. Bruen, B. K, Docteur, E., Lopert, R., Cohen, J., DiMasi, J., Dor, A., Neumann, P., DeSantis, R., & Shih, C.
abstract   bibtex   
Methods & Analytical FrameWork................................................................................................................ 4 Defining Key Terms ................................................................................................................................... 4 Development of an Analytic Framework .................................................................................................. 8 Analysis of Key Characteristics of Reimbursement Methods ................................................................... 8 Expert Consultations................................................................................................................................. 9 Case Studies .............................................................................................................................................. 9 Results......................................................................................................................................................... 11 Tracing the Link from Reimbursement to Innovation............................................................................. 12 Key Characteristics of Reimbursement Methods ................................................................................... 13 How Reimbursement Characteristics Affect Components of ROI and Incentives to Innovate .............. 22 The Reimbursement Decision-Making Process................................................................................... 22 Product Categorization and Differentiation........................................................................................ 29 Method of Payment............................................................................................................................ 36 Defining the Payment Amount ........................................................................................................... 41 Patient Cost Sharing............................................................................................................................ 47 Conclusion................................................................................................................................................... 54 Suggestions for Future Research ........................................................................................................ 57 Appendix A: A Standard Reimbursement Decision-Making Process .......................................................... 60 Appendix B: hi HealthInnovations Case Study............................................................................................ 62 Appendix C: Premera Value-Based Formulary Case Study ......................................................................... 72 Appendix D: NICE (UK) Performance-Based Reimbursement for Velcade® ............................................... 83 Appendix E: Expert Panelists....................................................................................................................... 93
@article{bruen_impact_nodate,
	title = {The {Impact} of {Reimbursement} {Policies} and {Practices} on {Healthcare} {Technology} {Innovation}},
	abstract = {Methods \& Analytical FrameWork................................................................................................................ 4 Defining Key Terms ................................................................................................................................... 4 Development of an Analytic Framework .................................................................................................. 8 Analysis of Key Characteristics of Reimbursement Methods ................................................................... 8 Expert Consultations................................................................................................................................. 9 Case Studies .............................................................................................................................................. 9
Results......................................................................................................................................................... 11 Tracing the Link from Reimbursement to Innovation............................................................................. 12 Key Characteristics of Reimbursement Methods ................................................................................... 13 How Reimbursement Characteristics Affect Components of ROI and Incentives to Innovate .............. 22 The Reimbursement Decision-Making Process................................................................................... 22 Product Categorization and Differentiation........................................................................................ 29 Method of Payment............................................................................................................................ 36 Defining the Payment Amount ........................................................................................................... 41 Patient Cost Sharing............................................................................................................................ 47
Conclusion................................................................................................................................................... 54 Suggestions for Future Research ........................................................................................................ 57 Appendix A: A Standard Reimbursement Decision-Making Process .......................................................... 60 Appendix B: hi HealthInnovations Case Study............................................................................................ 62 Appendix C: Premera Value-Based Formulary Case Study ......................................................................... 72 Appendix D: NICE (UK) Performance-Based Reimbursement for Velcade® ............................................... 83 Appendix E: Expert Panelists....................................................................................................................... 93},
	language = {en},
	author = {Bruen, Brian K and Docteur, Elizabeth and Lopert, Ruth and Cohen, Joshua and DiMasi, Joseph and Dor, Avi and Neumann, Peter and DeSantis, Regina and Shih, Chuck},
}

Downloads: 0